Results 171 to 180 of about 2,148,940 (313)

The importance of older patients’ experiences with care delivery for their quality of life after hospitalization [PDF]

, 2015
Jacqueline M. Hartgerink, Jane Murray Cramm, T. J. E. M. Bakker, Johan P. Mackenbach, Anna P. Nieboer   +4 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Exploring barriers and facilitators to achieving quality antenatal care in Ethiopia: a qualitative study. [PDF]

BMC Health Serv Res
Alemu AA, Welsh A, Getachew T, Khajehei M.   +3 more
europepmc   +1 more source

Improvements in Data Quality for Decision Support in Intensive Care

, 2011
Filipe Portela, Marta Vilas-Boas, Manuel Filipe Santos   +2 more
openalex   +2 more sources

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Quality of care

The ASHA Leader, 2012
Costa, Patrícia, Passos, A. M., Silva, S. A., Tavares, S. M.   +3 more
openaire   +3 more sources

Digital Transformation in Critical Care: Implications for Quality of Care, Infection Control, and Clinical Outcomes. [PDF]

J Clin Med
Toma D, Ghenciu LA, Bedreag OH, Băloi A, Gizea CA, Rițiu SA, Stoicescu ER, Bârsac CR, Păpurică M, Rogobete A, Săndesc D.   +10 more
europepmc   +1 more source

Fostering Quality Improvement Capacity in a Network of Primary Care Practices Affiliated With a Pediatric Accountable Care Organization

, 2019
Charitha Gowda, Christina Toth, Suzanne Hoholik, Richard J. Brilli, Sean Gleeson, Stephen Cardamone   +5 more
openalex   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Access to quality trauma care after injury in Pakistan: a systematic review and narrative synthesis. [PDF]

BMJ Open
Atiq H, Rahim KA, Shiekh SA, Afzal B, Wajidali Z, Chand ZB, Latif A, Ignatowicz A, Ghalichi L, Chu K, Razzak JA, Davies J.   +11 more
europepmc   +1 more source